Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 2 1Phase 1 1

Status

Completed 6Recruiting 4Active not recruiting 1

Sponsor Class

OTHER 5INDUSTRY 1

Study Type

Interventional 4Observational 2

Sponsor

Cancer Type

Breast 2Tumor-Agnostic 1Thoracic 1

Conditions

Hemangioma 2Breast Neoplasms 2Postoperative Nausea and Vomiting 1Pain, Postoperative 1Pain 1Neoplasms 1Hyperalgesia 1Heart Failure 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cyclophosphamide 1499Cisplatin 1435Paclitaxel 1340Radiotherapy 1310Carboplatin 1267Gemcitabine 1226Docetaxel 1133Bevacizumab 1070Fluorouracil 906Doxorubicin 805Dexamethasone 755Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 700Etoposide 679Irinotecan 639Filgrastim 624Cytarabine 587Nivolumab 586Leucovorin 583Vincristine 517Cetuximab 479Prednisone 478Bortezomib 474Trastuzumab 468Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 444Lenalidomide 436

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Completed × Adrenergic beta-Antagonists × Clear all
NCT05387512 2026-04-06

Real-world Association Between Concomitant Beta-blocker Exposure and Anti-PD-1/PD-L1 Treatment Outcomes in Advanced Non-Small Cell Lung Cancer

Affiliated Hospital of Nantong University

Completed
60 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02907021 2020-10-09

SCHOLAR

Population Health Research Institute

Phase 1 Completed
20 enrolled
Breast

Breast Neoplasms, Heart Failure

NCT01908972 2018-12-19

The Safety and Efficiency of Propranolol as an Initial Treatment for Pediatric Hemangioma

Seoul National University Hospital

Phase 4 Completed
34 enrolled 18 charts

Hemangioma

NCT01544959 2018-10-24

PAINFree

Université de Sherbrooke

Phase NA Completed
84 enrolled
Breast

Breast Neoplasms, Hyperalgesia, Pain, Pain, Postoperative, Postoperative Nausea and Vomiting

NCT01072045 2014-12-02

Comparative Study of the Use of Beta Blocker and Oral Corticosteroid in the Treatment of Infantile Hemangioma

University of Sao Paulo

Phase 2 Completed
50 enrolled

Hemangioma

NCT02215733 2014-08-13

The Use of Angiotensin Receptor Blockers and the Risk of Cancer

Boehringer Ingelheim

Completed
1,165,781 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡